Crise des opioïdes aux États-Unis : quelles implications pour la Suisse ? [Opioid crisis in the USA: what are implications for Switzerland?]
Details
Request a copy Under embargo until 18/03/2026.
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
UNIL restricted access
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_58827A409D5F
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Crise des opioïdes aux États-Unis : quelles implications pour la Suisse ? [Opioid crisis in the USA: what are implications for Switzerland?]
Journal
Revue medicale suisse
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
18/09/2024
Peer-reviewed
Oui
Volume
20
Number
887
Pages
1660-1663
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Publication Status: ppublish
Abstract
Warnings in Europe signal a rise in illicitly-manufactured fentanyl and other high potency synthetic opioids which could destabilize drug markets, strain health systems, and escalate harms of substance use and death. Here, we provide an overview of fentanyl in North America, drawing implications for Switzerland. Fentanyl withdrawal starts sooner, is more severe, and has worse anxiety and pain. Clinical care includes aggressive use of full agonist opioids, opioid agonist therapies (OAT) and adjunctive medications for acute withdrawal, and a need for low-threshold, readily accessible OAT to engage patients and mitigate harms. The US experience suggests the importance of widespread naloxone distribution, peer-based initiatives, early warning systems, and partnerships across patient-groups, healthcare systems, and public health.
Keywords
Humans, Switzerland/epidemiology, United States/epidemiology, Analgesics, Opioid/adverse effects, Analgesics, Opioid/administration & dosage, Opioid Epidemic/prevention & control, Fentanyl/adverse effects, Fentanyl/administration & dosage, Opioid-Related Disorders/epidemiology, Opioid-Related Disorders/prevention & control, Substance Withdrawal Syndrome, Naloxone/therapeutic use, Naloxone/administration & dosage
Pubmed
Create date
25/09/2024 8:29
Last modification date
04/10/2024 6:04